According to our (Global Info Research) latest study, the global Microarray Services market size was valued at US$ 439 million in 2025 and is forecast to a readjusted size of US$ 687 million by 2032 with a CAGR of 6.4% during review period.
Microarray Services refer to outsourced services provided by third-party genomics service providers or laboratories—utilizing microarray platforms—that encompass sample quality control, nucleic acid extraction, labeling, hybridization, scanning, signal detection, data normalization, bioinformatics analysis, and report delivery for their clients. Their primary clientele includes pharmaceutical companies, biotechnology firms, CROs, hospitals, research institutions, agricultural breeding enterprises, and public health laboratories.
The microarray services market is experiencing strong growth driven by advances in genomics, personalized medicine, and molecular diagnostics. With the growing demand for detailed genetic information, especially in areas such as oncology and rare disease research, microarray technology has become a valuable resource for comprehensive gene expression profiling, single nucleotide polymorphism (SNP) analysis, and epigenetic studies. Microarrays are able to analyze thousands of gene sequences in parallel, providing high-throughput data that is critical for precision medicine applications. The technology's ability to analyze complex genetic interactions and identify disease markers has driven its use in clinical diagnostics, contributing significantly to market growth. In addition, technological innovations such as next-generation microarrays with higher sensitivity and specificity are supporting the development of customized and customizable arrays to meet specific research needs, including agricultural and pharmacogenomics applications. Technological advances in microarrays are also contributing to market growth by improving data accuracy, sensitivity, and scalability. The rise of specialized microarrays tailored for specific applications, including DNA methylation and epigenetic studies, has enabled a deeper understanding of gene regulatory mechanisms, which is critical for studying diseases such as autoimmune diseases and cancer. In addition, the COVID-19 pandemic has accelerated the demand for microarray services as the technology can quickly perform genetic analysis of viruses and their variants, further validating the use of microarrays in infectious disease research. While the cost-effectiveness of microarrays compared to next-generation sequencing (NGS) has maintained its relevance, the continued reduction in NGS costs has created competitive pressure, prompting microarray service providers to focus on improving quality and providing comprehensive data interpretation services. As these technology and application-driven expansions are underway, the microarray services market is expected to maintain a strong growth trajectory, supported by increased research funding and government initiatives around the world.
This report is a detailed and comprehensive analysis for global Microarray Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Microarray Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Microarray Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Microarray Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Microarray Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Microarray Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Microarray Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Agilent Technologies, Eurofins Genomics, Azenta Life Sciences, Psomagen, LC Sciences, CD Genomics, Arraystar, Creative Biolabs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Microarray Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Gene Expression Microarray
Genotyping Microarray
Methylation Microarray
Transcriptome Microarray
Market segment by Platform
Custom Probe Array-Based Services
Protein Array Platform-Based Services
Others
Market segment by User
Pharmaceutical And Biotechnology Companies
CROs And Clinical Research Organizations
Academic And Research Institutes
Hospitals And Diagnostic Laboratories
Agricultural Biotechnology Companies
Government And Public Health Laboratories
Biobanks And Population Genomics Programs
Others
Market segment by Application
Drug Discovery And Development
Biomarker Discovery
Clinical Research
Pharmacogenomics
Cancer Research
Epigenetics Research
Agricultural Genomics
Others
Market segment by players, this report covers
Illumina
Thermo Fisher Scientific
Agilent Technologies
Eurofins Genomics
Azenta Life Sciences
Psomagen
LC Sciences
CD Genomics
Arraystar
Creative Biolabs
RayBiotech
Macrogen
BGI Genomics
Novogene
Takara Bio
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Microarray Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Microarray Services, with revenue, gross margin, and global market share of Microarray Services from 2021 to 2026.
Chapter 3, the Microarray Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Microarray Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Microarray Services.
Chapter 13, to describe Microarray Services research findings and conclusion.
Summary:
Get latest Market Research Reports on Microarray Services. Industry analysis & Market Report on Microarray Services is a syndicated market report, published as Global Microarray Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Microarray Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.